Fortis Healthcare delivered strong Q4 and full-year FY26 financial results.

Q4 revenue grew 17.8% to 2,365 Cr, with profit (PAT) soaring 44.2% to 271 Cr.

For the full year, revenue jumped 17.3% to 9,128 Cr, and PAT climbed 31.5% to 1,064 Cr.

The hospital business was a key driver, with revenue up 19.1% for FY26, boosted by growth in specialties like Renal Sciences & Orthopedics and increased international patient numbers.

Diagnostics also showed healthy revenue growth.

Strategic expansion included acquiring People Tree and Shrimann hospitals, adding around 500 beds.

Fortis is also investing in advanced medical technology like surgical robots and MRIs.

Management highlighted steady performance and ongoing investments, planning continued brownfield expansions and exploring further inorganic growth.

The board proposed a dividend of INR 1 per share.